Pharma

Alembic Pharmaceuticals Ltd

APLLTD · NSE · INE901L01018
₹814.5+0.64%consolidatedstandalone
Wednesday, 9 Sept 20262:17 pm
Sentiment55 · Neutral
Extreme FearFearNeutralGreedExtreme Greed
Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE12.4%
ROCE11.3%
ROE12.4%
1Y Return+1.74%
Avg. Volume0.1M

Price Chart

97889581272964620.1L40.1LSept 2025Oct 2025Nov 2025Jan 2026Feb 2026Mar 2026May 2026Jul 2026Sept 2026

52-Week Range

₹635.8₹814.5₹998
52W Low52W High

About

Alembic Pharmaceuticals Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap—
Current Price₹814.5
52W High / Low₹998 / ₹635.8
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE12.4%
1Y Return+1.74%
Day Change+0.64%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Sales₹7,784 Cr₹7,345 Cr₹6,672 Cr
Expenses₹6,617 Cr₹6,224 Cr₹5,664 Cr
Operating Profit₹1,167 Cr₹1,121 Cr₹1,008 Cr
OPM %15.0%15.0%15.0%
Other Income₹-1 Cr₹-14 Cr₹56 Cr
Depreciation₹342 Cr₹319 Cr₹279 Cr
Interest₹98 Cr₹94 Cr₹79 Cr
Profit Before Tax₹726 Cr₹694 Cr₹707 Cr
Tax₹36 Cr₹23 Cr₹125 Cr
Net Profit₹690 Cr₹671 Cr₹582 Cr
EPS (₹)35.334.329.7
Dividend Payout %—35%37%
Financial history locked

Register free to see 10 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹2,150 Cr₹1,848 Cr₹1,876 Cr₹1,910 Cr
Expenses₹1,818 Cr₹1,620 Cr₹1,585 Cr₹1,594 Cr
Operating Profit₹332 Cr₹228 Cr₹292 Cr₹316 Cr
OPM %15.0%12.0%16.0%17.0%
Depreciation₹98 Cr₹89 Cr₹80 Cr₹76 Cr
Interest₹28 Cr₹23 Cr₹23 Cr₹24 Cr
Net Profit₹172 Cr₹202 Cr₹132 Cr₹184 Cr
EPS (₹)8.810.36.89.4
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Liabilities
Equity Capital₹39 Cr₹39 Cr₹39 Cr
Reserves₹5,636 Cr₹5,152 Cr₹4,779 Cr
Borrowings₹1,430 Cr₹1,258 Cr₹513 Cr
Other Liabilities₹1,658 Cr₹1,324 Cr₹1,115 Cr
Total Liabilities₹8,763 Cr₹7,773 Cr₹6,446 Cr
Assets
Fixed Assets₹3,081 Cr₹2,524 Cr₹2,547 Cr
Investments₹141 Cr₹127 Cr₹93 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹4,858 Cr₹4,285 Cr₹3,281 Cr
Total Assets₹8,763 Cr₹7,773 Cr₹6,446 Cr
Balance sheet history locked

Register free to see 10 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹783 Cr₹-506 Cr₹-164 Cr₹113 Cr
FY25₹88 Cr₹-568 Cr₹444 Cr₹-37 Cr
FY24₹803 Cr₹-321 Cr₹-438 Cr₹45 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
FY15
Cash flow history locked

Register free to see 10 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
Sun Pharmaceutical Industries Ltd——+14.78%+7.18%
Dr Reddys Laboratories Ltd——+8.84%-3.74%
Cipla Ltd——+11.77%-5.50%
Apollo Hospitals Enterprise Ltd——+22.64%+23.01%
Divis Laboratories Ltd₹2,50,065 Cr83.9+16.5%+46.29%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-07Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015 - Incorporation Of A Wholly Owned Subsidiary CompanyBSE Filing2026-08-04Alembic Pharmaceuticals Ltd (BOM:533573) (Q1 2027) Earnings Call Highlights: Strong Revenue ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.